Valneva SE (VALN) Short term Debt (2020 - 2026)
Valneva SE (VALN) posted Short term Debt of $21.4 million for Q1 2026, up 2.63% sequentially from $20.8 million in Q4 2025, and up 3.2% YoY from $20.7 million in Q1 2025.
Valneva SE (VALN) Short term Debt (2020 - 2026) Analysis & Trends
Valneva SE has reported Short term Debt for 7 years, with the latest figure at $21.4 million in Q1 2026.
- Quarterly Short term Debt rose 3.2% year-over-year to $21.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $21.4 million (up 3.2% YoY) and the FY2025 annual result came in at $20.8 million, down 7.65% from the prior year.
- Short term Debt climbed to $21.4 million in Q1 2026 per VALN's latest filing, from $20.8 million in the prior quarter.
- Over five years, Short term Debt peaked at $68.8 million in Q3 2025 and troughed at $11.8 million in Q4 2022.
- A 5-year average of $26.2 million and a median of $21.4 million in 2026 frame the typical range for Short term Debt.
- The sharpest annual moves came in 2023 and 2024: Short term Debt soared 301.43% in 2023, then sank 53.02% in 2024.
- Over 5 years, Short term Debt stood at $11.8 million in 2022, then jumped by 301.43% to $47.4 million in 2023, then slumped by 53.02% to $22.3 million in 2024, then declined by 6.46% to $20.8 million in 2025, then gained by 2.63% to $21.4 million in 2026.
- According to Business Quant data, Short term Debt over the past three periods registered $21.4 million, $20.8 million, and $68.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Valneva SE | 618.67 Mn | 477.41 Mn | 1.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21.42 Mn |
| Mar 31, 2026 | 21.39 Mn |
| Dec 31, 2025 | 20.84 Mn |
| Sep 30, 2025 | 68.78 Mn |
| Jun 30, 2025 | 52.10 Mn |
| Mar 31, 2025 | 20.73 Mn |
| Dec 31, 2024 | 22.28 Mn |
| Sep 30, 2024 | 21.36 Mn |
| Jun 30, 2024 | 21.39 Mn |
| Mar 31, 2024 | 24.35 Mn |
| Dec 31, 2023 | 47.43 Mn |
| Sep 30, 2023 | 36.81 Mn |
| Jun 30, 2023 | 23.08 Mn |
| Mar 31, 2023 | 15.20 Mn |
| Dec 31, 2022 | 11.81 Mn |
| Sep 30, 2022 | 12.60 Mn |
| Jun 30, 2022 | 12.32 Mn |
| Mar 31, 2022 | 13.17 Mn |
| Dec 31, 2021 | 8.13 Mn |
| Dec 31, 2020 | 8.33 Mn |